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Introduction
An important aspect of the control of eukaryotic gene expres-
sion is the regulation of the mRNA translation and degradation, 
which are often intertwined. The control of translation and 
mRNA degradation can involve conserved cytoplasmic RNA 
granules, which are defi  ned as microscopically visible granules 
containing mRNA and proteins (Anderson and Kedersha, 2006). 
One class of cytoplasmic RNA granule is termed a processing 
body (P-body). P-bodies are dynamic aggregates of untranslat-
ing mRNA in conjunction with translation repressors and mRNA 
degradation components (Eulalio et al., 2007a; Parker and 
Sheth, 2007). P-bodies and the mRNPs assembled within them 
are of interest because they have been implicated in translation 
repression (Holmes et al., 2004; Coller and Parker, 2005), nor-
mal mRNA decay (Sheth and Parker, 2003; Cougot et al., 2004), 
nonsense-mediated decay (Unterholzner and Izaurralde, 2004; 
Sheth and Parker, 2006), microRNA (miRNA)-mediated repres-
sion (Liu et al., 2005; Pillai et al., 2005), and mRNA storage 
(Brengues et al., 2005; Bhattacharyya et al., 2006). In addition, 
P-bodies are related to cytoplasmic RNA granules containing 
translationally repressed mRNPs found in germ cells and neu-
rons (Barbee et al., 2006; Seydoux and Braun, 2006).
The mechanisms by which P-bodies form are largely un-
known. For example, the specifi  c protein–protein and protein–
RNA interactions that mediate the formation of an mRNP that 
is capable of being incorporated into a P-body are unclear. Sim-
ilarly, the interactions that mediate the aggregation of mRNPs 
together into microscopically visible structures are unknown. 
An important issue is to understand how P-bodies assemble and 
what the consequences of different scales of assembly are to the 
translation and degradation of mRNA.
P-bodies in yeast through mammals contain a conserved 
core of proteins (Anderson and Kedersha, 2006; Eulalio et al., 
2007a; Parker and Sheth, 2007). Some of these core proteins are 
involved in mRNA degradation, including the decapping en-
zyme Dcp1p/Dcp2p, the exonuclease Xrn1p, the Ccr4p–Pop2–
Notp deadenylase complex, and the decapping activators Dhh1p, 
Pat1p, Lsm1-7p, and Edc3p. Some of these proteins, like Dhh1p 
and Pat1p, have also been implicated in translation repression 
(Holmes et al., 2004; Coller and Parker, 2005). Metazoan P-bodies 
contain additional components, including proteins involved in 
miRNA-mediated repression such as argonaute, GW182, and 
Mov10 (Anderson and Kedersha, 2006; Eulalio et al., 2007a; 
Parker and Sheth, 2007).
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Several proteins have been implicated in P-body assem-
bly. For example, in mammalian cells, P-bodies are greatly re-
duced by knockdown of GW182, RCK/p54, RAP55, Lsm4, 
Lsm1, Hedls/Ge-1, 4E-T, or miRNA biogenesis in general (Andrei 
et al., 2005; Ferraiuolo et al., 2005; Jakymiw et al., 2005; Chu and 
Rana, 2006; Pauley et al., 2006). However, because translation 
and P-body formation compete with each other, the lack of a 
specifi  c protein can affect P-body formation by either reducing 
the pool of nontranslating mRNA or decreasing the aggregation 
of nontranslating mRNPs into P-bodies. Strikingly, P-bodies 
are restored when translation initiation is inhibited by arsenite 
in mammalian cells depleted of Lsm4 (Kedersha et al., 2005). 
This observation argues that Lsm4, and possibly some of the other 
mammalian factors as well, is not required for P-body assembly 
per se, but instead contributes to P-body formation by increasing 
the pool of translationally repressed mRNA. Thus, to understand 
how P-bodies form, it is important to distinguish whether a 
component functions in translation repression or in the actual 
aggregation of mRNPs with each other.
Genetic analyses of P-body assembly in yeast revealed 
that certain components are dependent on one another for 
their association with P-bodies and suggested that P-body 
formation was redundant, with partial roles being played by 
Dcp2p and Pat1p (Teixeira and Parker, 2007). However, the 
role of the P-body component Edc3p was not investigated. 
By analyzing the role of Edc3p in P-body assembly, we identi-
fi  ed direct physical interactions between components of yeast 
P-bodies that, in combination with previous observations, lead 
to a model for the core mRNP structure within P-bodies. 
We also demonstrated that these core mRNPs, or small mRNP 
complexes, can be aggregated into microscopically visible 
P-bodies either through Edc3p acting as a scaffold protein 
and interacting with itself to interconnect mRNPs or by an ag-
gregation mechanism dependent on the glutamine/asparagine 
(Q/N)-rich prionlike domain in Lsm4p. These results suggest 
a stepwise model for P-body assembly with the initial forma-
tion of a core mRNA–protein complex that then aggregates 
through multiple specifi  c mechanisms.
Results
Edc3p functions in P-body formation
To test the role of Edc3p in P-body assembly, we examined the 
ability of edc3∆ strains to form P-bodies. In edc3∆ strains, 
Dcp1pGFP and Dcp2pGFP were no longer seen in the small 
P-bodies normally observed in mid-log cultures in wild-type 
strains (Fig. 1 A, left). Moreover, during glucose deprivation, 
where P-bodies are large (Teixeira et al., 2005), we observed 
that edc3∆ strains showed a strong reduction in the accumula-
tion of multiple proteins into microscopically visible P-bodies 
(Fig. 1 A, left), although some P-bodies could still form (see the 
following paragraph). The edc3∆ strain also showed reduced 
P-body assembly in response to osmotic stress and in the station-
ary phase (not depicted). It should be noted that we were unable 
to determine if P-bodies too small to be detected in the light 
microscope were forming (see Discussion). Nevertheless, the 
strong reduction of P-bodies, as judged by six different proteins 
and under different growth conditions, indicates that Edc3p af-
fects the formation of P-bodies.
We observed that the magnitude of the reduction of 
P-bodies in the edc3∆ strain was dependent on the experimental 
conditions used. Most strikingly, if aeration was limited during 
glucose deprivation, Edc3p was required for P-body accumula-
tion (Fig. 2 A). In contrast, if cells were deprived of glucose 
while being strongly aerated, edc3∆ strains still formed P-bodies, 
although at reduced levels compared with wild-type cells (Fig. 2 A). 
These results suggested that there is also an Edc3-independent 
mode for forming P-bodies that is dependent on mitochondrial 
respiration. To test this possibility, we isolated and examined 
petite versions of wild-type and edc3∆ strains that are respiratory 
defi  cient (Fox et al., 1991). P-bodies increased in response to 
glucose deprivation in respiratory-defi  cient, but otherwise wild-
type, cells, as judged by the increase in Dcp2GFP and Dhh1GFP 
foci (Fig. 2 A). In contrast, no Dcp2GFP or Dhh1GFP foci were 
observed after glucose removal in the edc3∆ strain that was re-
spiratory defi  cient (Fig. 2 A). These results indicate that Edc3p 
plays a role in P-body assembly, although there is a second res-
piration-dependent mechanism during glucose deprivation that 
can contribute to P-body assembly.
Additional evidence that Edc3p affects, but is not required 
for, P-body assembly is that the large P-bodies that form in 
dcp1∆ or xrn1∆ strains because of the resulting defects in de-
capping and 5′-to-3′ degradation (Sheth and Parker, 2003; Teixeira 
and Parker, 2007) are reduced but not eliminated in dcp1∆ edc3∆ 
and xrn1∆ edc3∆ strains (Fig. 1 B).
Edc3p is required for P-body assembly 
but not for translation repression
The strong reduction of P-bodies in the respiratory-defi  cient 
edc3∆ strain during glucose deprivation suggests that Edc3p 
could either be required for the aggregation of mRNPs into 
P-bodies or for translational repression during glucose deprivation. 
To distinguish these two possibilities, we examined whether the 
respiratory-defi  cient edc3∆ strain could repress translation during 
glucose deprivation, as judged by polysome analysis.
We observed that both respiratory-defi  cient wild-type or 
edc3∆ cells showed a similar reduction in polysomes during 
glucose deprivation (Fig. 2 B). Because Edc3p is required for 
P-body formation under these conditions, this observation indi-
cates that Edc3p primarily functions in the aggregation of non-
translating mRNPs into P-bodies. This result also implies that 
aggregation of mRNPs into microscopically visible P-bodies is 
not required for translation repression, at least in response to 
glucose deprivation.
Different domains of Edc3p interact with 
Edc3p, Dcp2p, and Dhh1p
These results identify Edc3p as a factor that contributes to the 
assembly of microscopically visible P-bodies. Edc3p is a mem-
ber of the Lsm16 family of proteins and contains at its N termi-
nus a divergent Lsm, or like-Sm, domain, a central FDF domain 
of unknown function containing the amino acid motif FDF, and a 
C-terminal YjeF-N domain that resembles the N-terminal domain 
of the Escherichia coli Yjef protein (Albrecht and Lengauer, 2004; YEAST P-BODY ASSEMBLY MECHANISMS • DECKER ET AL. 439
Anantharaman and Aravind, 2004). To determine how these dif-
ferent Edc3 domains contribute to P-body assembly, we exam-
ined the interactions of each of these domains in two-hybrid 
tests with other P-body components and verifi  ed interactions by 
direct binding experiments with recombinant proteins.
In two-hybrid assays (Fig. 3 A), full-length Edc3p inter-
acted with Edc3p, Dcp1p, the C-terminal structural domain of 
Dhh1p (Cheng et al., 2005), and the conserved region of Dcp2p 
(amino acids 1–300). The conserved region of Dcp2p is com-
posed of two distinct structural domains: an N-terminal domain 
that interacts with Dcp1p and a C-terminal domain that contains 
the catalytic site (She et al., 2006). The C-terminal catalytic do-
main of Dcp2p encompassing amino acids 102–300 was suffi  -
cient to interact with full-length Edc3p. Subsequent experiments 
revealed that each of these interactions involved a specifi  c do-
main of Edc3p.
Two observations indicate that the catalytic domain of 
Dcp2p (residues 102–300) primarily interacts with the Lsm 
Figure 1.  Edc3p is important for P-body assembly. 
(A) Localization of Dhh1GFP, Pat1GFP, Lsm1GFP, Dcp-
1GFP, Dcp2GFP, and Xrn1GFP in wild-type and edc3∆ 
strains during exponential growth in YP with (+glu) or 
without (−glu) glucose for 10 min. (B) Localization of 
Dhh1GFP, Dcp2GFP, and Xrn1GFP in dcp1∆ or 
dcp1∆ edc3∆ strains or Dhh1GFP, Dcp2GFP, and Pat-
1GFP in xrn1∆ or xrn1∆ edc3∆ strains during expo-
nential growth in YP containing glucose. Bars, 3 μm.JCB • VOLUME 179 • NUMBER 3 • 2007  440
domain of Edc3p. First, the Lsm domain is suffi  cient in the two-
hybrid assay to interact with residues 102–300 of Dcp2p (Fig. 
3 A). Second, a His-tagged Lsm domain binds to recombinant 
Flag-tagged Dcp2p (either 1–300 or 102–300) in an in vitro 
pull-down assay from bacterial lysates (Fig. 3 B). Lysates were 
used because the Lsm domain became insoluble when concen-
trated during purifi  cation. The Lsm domain was not pelleted by 
the anti-Flag resin alone (Fig. 3 B) or by GST-tagged Dhh1p 
(Fig. 3 D), indicating that the Lsm domain–Dcp2p interaction is 
specifi  c. These results identify the Lsm domain as a region of 
Edc3p that directly binds the catalytic domain of Dcp2p.
Two observations indicate that Dcp2p also interacts with 
the FDF domain of Edc3p. First, although the FDF domain is 
not suffi  cient for a two-hybrid interaction with Dcp2p, a com-
bined Lsm–FDF construct shows a stronger interaction with the 
catalytic domain of Dcp2p than just the Lsm domain (Fig. 3 A). 
Second, the purifi  ed FDF domain could be affi  nity purifi  ed with 
both the Flag-tagged 1–300–amino acid fragment and the 102–300–
amino acid fragment of Dcp2p, although this interaction is sen-
sitive to moderate salt (Fig. 3 C). These results identify the FDF 
domain as a region that can directly bind Dcp2p, albeit weakly.
Two observations indicate that the FDF domain can di-
rectly interact with the C-terminal domain of Dhh1p as well. 
First, the FDF domain was suffi  cient in two-hybrid experiments 
to interact with this portion of Dhh1p (Fig. 3 A). Second, re-
combinant Dhh1p interacted with recombinant FDF domain in 
an in vitro pull-down assay (Fig. 3 E). Moreover, the in vitro in-
teraction between the FDF domain and Dhh1p only required the 
C-terminal domain of Dhh1p (Fig. 3 E). In contrast, purifi  ed 
Dhh1p failed to interact with the Lsm domain of Edc3p in pull-
down experiments (Fig. 3 D). These results identify the FDF 
domain as a site that directly binds Dhh1p.
Figure 2.  When cells are unable to respire, Edc3p is required for P-body assembly, but not for translation repression, in response to glucose deprivation. 
(A) Localization of Dcp2GFP or Dhh1GFP in respiratory-competent or -deﬁ  cient wild-type or edc3∆ strains during exponential growth in YP containing glu-
cose (+glu, +aeration), deprived of glucose for 10 min while being aerated (−glu, +aeration), or deprived of glucose for 10 min while concentrated in 
a microcentrifuge tube (−glu, −aeration). Bar, 3 μm. (B) Polysome proﬁ  les, A254 traces of sucrose density gradients, were obtained from respiratory-deﬁ  cient 
wild-type or edc3∆ strains grown under standard growth conditions (+glu) or deprived of glucose for 10 min while being aerated (−glu).YEAST P-BODY ASSEMBLY MECHANISMS • DECKER ET AL. 441
The YjeF-N domain of Edc3p can interact with itself and 
was suffi  cient to interact with Edc3p (Fig. 3 A). This is consistent 
with genome-wide analyses that have identifi  ed the C terminus 
of Edc3p as being suffi  cient to interact with itself by two-hybrid 
or phage display experiments (Fromont-Racine et al., 2000; 
Marino-Ramirez and Hu, 2002).
We also obtained evidence that the C-terminal domain of 
Dhh1p binds directly to the catalytic domain of Dcp2p. Specifi  -
cally, we observed a two-hybrid interaction between these do-
mains of Dhh1p and Dcp2p (unpublished data). In addition, in 
binding experiments with purifi  ed recombinant proteins, GST-
tagged Dhh1p pulled down Dcp2p (Fig. 3 F), and reciprocally 
GST-tagged Dhh1p was pulled down by Flag-tagged Dcp2p (not 
depicted). In these experiments, the catalytic domain of Dcp2p 
(residues 102–300) was suffi  cient to bind to Dhh1p (Fig. 3 F). 
In addition, the C-terminal domain, but not the N-terminal 
domain, of Dhh1p was suffi  cient to bind to Dcp2p (unpublished 
data). These data indicate that the C-terminal domain of Dhh1p 
directly interacts with the catalytic domain of Dcp2p.
The Lsm and Yjef-N domains of Edc3p are 
required for its function in the formation of 
microscopically visible P-bodies
These results identify three different domains of Edc3p that 
interact with specifi  c P-body components. To determine how 
these domains contribute to P-body formation, we deleted each 
domain of Edc3p and asked if the mutant protein could rescue 
the P-body aggregation defect of the respiratory-defi  cient edc3∆ 
strain, where P-body formation is strongly dependent on Edc3p. 
We examined the formation of Dcp2GFP foci in both exponen-
tially growing cells and during glucose deprivation. As ex-
pected, expression of full-length Edc3p complemented the 
P-body aggregation defect of the edc3∆ strain under both con-
ditions (Fig. 4). Edc3p lacking the FDF domain functioned in 
P-body assembly (Fig. 4). In contrast, deletion of either the Lsm 
or Yjef-N domains caused defects in the formation of Dcp2GFP 
(Fig. 4) and Dhh1GFP foci (Fig. S1, available at http://www
.jcb.org/cgi/content/full/jcb.200704147/DC1) both in exponen-
tially growing cells and under glucose deprivation. The defect 
in P-body aggregation in cells expressing the ∆Lsm and ∆Yjef-N 
proteins was not simply caused by decreased expression be-
cause the amount of these mutant proteins was not substantially 
decreased relative to full-length Edc3p (Fig. S2, A and B). 
Figure 3.  Edc3p interacts with itself, Dcp2p, and Dhh1p through distinct 
domains. (A) Summary of two-hybrid protein interaction assays between 
full-length or the indicated deleted versions of Edc3p and full-length Dcp1p 
or Edc3p, the conserved region of Dcp2p (amino acids 1–300), the cata-
lytic domain of Dcp2p (amino acids 102–300), or a C-terminal fragment 
of Dhh1p (amino acids 250–461). +++, ++, and + indicate relative 
positive interaction based on β-galactosidase assays. — indicates no de-
tectable interaction. (B) An in vitro binding assay between puriﬁ  ed His-
Dcp2(1–300)-Flag or His-Dcp2(102–300)-Flag and E. coli lysate containing 
the His-tagged Lsm domain of Edc3p in the presence of 225 mM NaCl. 
Anti-Flag afﬁ  nity resin was used to pull down (PD) the Flag-tagged Dcp2 
proteins and anti-His antibody used in Western blots (WB) to detect the 
His-tagged Lsm domain. Total (T) lanes represent 1/8 of the material 
loaded in the pellet (P) lanes. (C) An in vitro binding assay between puri-
ﬁ  ed His-Dcp2(1–300)-Flag or His-Dcp2(102–300)-Flag and a puriﬁ  ed His-
tagged FDF domain of Edc3p in the presence of 100 or 225 mM NaCl. 
Total lanes represent 1/8 of the material loaded in the pellet lanes. (D) An 
in vitro binding assay between puriﬁ  ed GST, GST-tagged Dhh1(46–461) 
or Dhh1(250–461), and an E. coli lysate containing a His-tagged Lsm do-
main of Edc3p. Glutathione-Sepharose was used to pull down the GST-
tagged Dhh1 proteins and anti-His antibody was used in Western blots to 
detect the His-tagged Lsm domain. Total lanes represent 1/8 of the material 
loaded in the pellet lanes. (E) An in vitro binding assay between puriﬁ  ed 
GST, GST-tagged Dhh1(46–461) or Dhh1(250–461), and a puriﬁ  ed His-
tagged FDF domain of Edc3p. Total lanes represent 1/8 of the material 
loaded in the pellet lanes. (F) An in vitro binding assay between puriﬁ  ed 
GST or GST-tagged Dhh1(46–461) and His-Dcp2(1–300)-Flag or His-
Dcp2(102–300)-Flag. Glutathione-Sepharose was used to pull down the 
GST-tagged Dhh1 protein and anti-His antibody used in Western blots to 
detect the His-tagged Dcp2 proteins. Total lanes represent 1/8 of the mate-
rial loaded in the pellet lanes.JCB • VOLUME 179 • NUMBER 3 • 2007  442
Moreover, the decrease in Dcp2GFP foci was not caused by the 
deletion of the Lsm or Yjef-N domains of Edc3p reducing the 
levels of Dcp2 protein (Fig. S2 C). These results identify the Lsm 
and Yjef-N domains of Edc3p as being required for P-body 
aggregation and suggest that Edc3p acts as a scaffold protein 
that links multiple mRNPs together.
The Q/N-rich prionlike domain of Lsm4p 
is required for P-body assembly in the 
absence of Edc3p
As described earlier, our analysis indicated that there is also an 
Edc3-independent mechanism by which microscopically visible 
P-bodies can form. Interestingly, a component of the Lsm1-7p 
complex, Lsm4p, has a C-terminal Q/N-rich domain, which has 
been categorized as a prionlike domain (Michelitsch and Weissman, 
2000). Moreover, Lsm4p can function in a similar manner to 
known yeast prion proteins in that it can induce the [PSI+] 
prion when overexpressed (Derkatch et al., 2001). Thus, we hy-
pothesized that the Edc3p-independent mode of P-body aggre-
gation might involve the Lsm4p Q/N-rich domain. To test this 
model, we deleted the C-terminal 97 amino acids encompassing 
the Q/N-rich sequence within Lsm4p and assayed the effect of this 
deletion on P-body formation in the absence of Edc3p. The lsm4∆C 
and lsm4∆C edc3∆ strains were viable, indicating that the trun-
cated protein is being expressed because Lsm4p is essential.
An important result was that the lsm4∆C edc3∆ strain was 
defective in P-body formation during glucose deprivation (Fig. 
5 A, right). In contrast, deletion of the C terminus of Lsm4 pro-
tein by itself did not reduce P-bodies during mid-log growth or 
have a strong effect on P-body formation in response to glucose 
deprivation (Fig. 5 A). This result indicates that either Edc3p or 
the prionlike domain of Lsm4p is suffi  cient for P-body aggrega-
tion during glucose deprivation. It should be noted that small 
Dcp2GFP foci were occasionally observed in the lsm4∆C 
edc3∆ strain, indicating that microscopically visible P-bodies 
can assemble, though ineffi  ciently, in the absence of both Edc3p 
and the C terminus of Lsm4p. Nevertheless, the severe defect in 
P-body formation in the lsm4∆C edc3∆ mutant identifi  es the 
Q/N-rich domain of Lsm4p as a second protein domain that can 
affect the formation of microscopically visible P-bodies.
Because Dcp2GFP was used as a marker for P-bodies, it 
was formally possible that the Q/N-rich domain of Lsm4p was 
solely required for the localization of Dcp2p to P-bodies in the 
absence of Edc3p. To verify that the lsm4∆C edc3∆ deletion 
mutant was defective for P-body formation, we examined the 
localization of the reporter mRNA MFA2P-U1A, which con-
tains binding sites for the U1A protein by coexpressing U1A 
protein fused to GFP. This reporter mRNA accumulates in 
P-bodies after glucose deprivation (Brengues et al., 2005). 
As shown in Fig. 5 B, the lsm4∆C edc3∆ mutant has a severe 
defect in the accumulation of the MFA2P-U1A reporter mRNA in 
response to glucose deprivation. This observation supports the 
interpretation that both the Q/N-rich domains of Lsm4p and 
Edc3p contribute to P-body formation.
The Q/N domain of Lsm4p could affect P-body formation 
by being required for translation repression during glucose de-
privation in the edc3∆ strain or the aggregation of translation-
ally repressed mRNPs in the absence of Edc3p. To distinguish 
these two possibilities, we examined the extent of translation 
repression in the lsm4∆C edc3∆ strain during glucose depriva-
tion. We observed that deletion of the Lsm4 prionlike domain in 
combination with deletion of Edc3p did not interfere with trans-
lation repression under these conditions (Fig. 5 C). This indi-
cates that the defect in P-body formation in the lsm4∆C edc3∆ 
strain during glucose deprivation is not caused by a failure to 
repress translation. Thus, these results demonstrate that a sec-
ond mechanism for P-body aggregation is based on the Lsm4 
Q/N-rich domain.
The simplest model for how the Lsm4 Q/N-rich domain 
contributes to P-body formation is that it aggregates with itself, 
or other Q/N-rich domains, in a manner analogous to the as-
sembly mechanism for Q/N-rich domains in known prions. 
However, given the dynamic and reversible nature of P-body 
assembly, such interactions mediated by the Lsm4 Q/N-rich 
domain would not be heritable like a classical prion. To test 
whether the Q/N-rich domain of Lsm4 functions analogously 
to a prion, we asked whether it could be substituted by the 
Q/N-rich prion domain of a known yeast prion protein, Rnq1p 
(Sondheimer and Lindquist, 2000). The C terminus of Lsm4p was 
replaced by the prion domain of Rnq1p, and the fusion protein 
Figure 4.  The Lsm and Yjef-N domains are required for Edc3p to function 
in P-body assembly. Localization of Dcp2GFP in a respiratory-deﬁ  cient 
edc3∆ strain expressing from a plasmid Flag-tagged full-length Edc3p, no 
Edc3p, or versions of Flag-tagged Edc3p in which the Lsm, FDF, or Yjef-N 
domains were deleted during exponential growth in SC containing glucose 
(+glu) or after being deprived of glucose for 10 min under aeration (−glu). 
Bar, 3 μm.YEAST P-BODY ASSEMBLY MECHANISMS • DECKER ET AL. 443
was tested for its ability to form Dcp2GFP foci in cells lacking 
both Lsm4p and Edc3p. In the lsm4∆ edc3∆ strain expressing 
the Lsm4Rnq1 fusion protein, Dcp2GFP foci were observed in 
exponentially growing cells and were increased after glucose 
deprivation (Fig. 5 A, bottom). Thus, the prion domain of Rnq1p 
was able to functionally replace the Q/N-rich domain of Lsm4p 
for the assembly of P-bodies, which is consistent with Lsm4p 
promoting P-body assembly via a prionlike aggregation mecha-
nism. Interestingly, the Dcp2GFP foci seen in exponentially 
growing cells expressing the Lsm4Rnq1 fusion protein were 
more intense than those seen in cells expressing wild-type Lsm4 
protein. The ability of the Rnq1 Q/N-rich domain to enhance 
P-body formation during exponential growth argues that specifi  c 
features of the Lsm4 Q/N-rich domain are required for the highly 
reversible nature of P-body formation.
Edc3p- and Lsm4p-driven aggregation does 
not substantially affect mRNA decay
Our results defi  ne two major mechanisms that allow the forma-
tion of microscopically visible P-bodies. This provides an op-
portunity to examine the functional signifi  cance of aggregation 
of mRNPs into larger P-body structures. Because the lsm4∆C 
edc3∆ strain represses translation during glucose deprivation, 
but is severely defective in forming visible P-bodies, we con-
clude that the effi  cient assembly of large visible P-bodies is not 
required for translation repression during glucose deprivation. 
To examine how the formation of large P-bodies contributes 
to mRNA decapping, we examined the decay of two reporter 
mRNAs, MFA2pG and PGK1pG (Decker and Parker, 1993), in 
edc3∆, lsm4∆C, and lsm4∆C edc3∆ strains as compared with 
the wild-type strain. Deletion of the Q/N-rich domain of Lsm4 
protein and the Edc3 protein did not substantially alter the decay 
rate of the unstable MFA2pG mRNA (Fig. 6 A) or the stable 
PGK1pG mRNA (not depicted), indicating that mRNA turnover 
is not strongly affected in cells lacking both P-body aggregation 
mechanisms. This result indicates that the aggregation of mRNPs 
together into microscopically visible P-bodies is not necessary 
for the basal control of mRNA decay rates. This observation 
indicates that assembly of a transcript into an individual mRNP 
containing the mRNA decapping proteins or into small com-
plexes not detected by light microscopy is suffi  cient for mRNA 
decapping under normal conditions (see Discussion).
Figure 5.  In the absence of Edc3p, the prionlike domain of 
Lsm4p is required for P-body aggregation, but not for transla-
tion repression, in response to glucose deprivation. (A) Local-
ization of Dcp2GFP in wild-type, edc3∆, lsm4∆C (deletion of 
C terminus of Lsm4 including the Q/N-rich prionlike domain), 
or lsm4∆C edc3∆ strains, or an lsm4∆ edc3∆ strain carrying 
a plasmid in which the C-terminal Q/N-rich domain of Lsm4p 
has been replaced with the prion domain of Rnq1p during ex-
ponential growth in YP containing glucose (+glu) or after be-
ing deprived of glucose for 10 min while being aerated 
(−glu). (B) Localization of MFA2P-U1A mRNA in wild-type or 
lsm4∆C edc3∆ strains deprived of glucose for 10 min while 
being aerated. The MFA2P-U1A mRNA was detected by co-
expressing U1A fused with GFP, which binds to the U1A bind-
ing sites within the 3′ UTR of the mRNA. Note that a different 
contrast range was used than the range in A because of the 
intense ﬂ  uorescence signal of the RNA foci in the wild-type cells. 
Bars, 3 μm. (C) Polysome proﬁ  les, A254 traces of sucrose 
density gradients, obtained from wild-type or lsm4∆C edc3∆ 
strains grown under standard growth conditions (+glu) or de-
prived of glucose for 10 min while being aerated (−glu).JCB • VOLUME 179 • NUMBER 3 • 2007  444
The Edc3 protein is known to enhance decapping under 
conditions where decapping rates are compromised by the con-
ditional allele of dcp2-7 (Kshirsagar and Parker, 2004). Given 
this, it was possible that the ability of Edc3p to enhance decap-
ping by the dcp2-7 protein could result from its function in ag-
gregating P-body components together, and thus concentrating 
decapping factors and substrate mRNA molecules together. Al-
ternatively, because Dcp2p can interact directly with the Lsm 
and FDF domains of Edc3p, Edc3p might stimulate Dcp2p 
function by direct physical interactions.
To test whether P-body aggregation by Edc3p enhances 
decapping, we examined the ability of the different domain de-
letion mutants of Edc3p to complement the edc3∆ decapping 
defect seen in dcp2-7 strains. As observed previously, edc3∆ 
exacerbates a partial defect in the decay of the MFA2pG mRNA 
at a low temperature caused by the temperature-sensitive allele 
dcp2-7 (Fig. 6 B). Deletion of EDC3 also slows growth in dcp2-7 
ski3∆ cells (Kshirsagar and Parker, 2004), in which 3′-to-5′ 
mRNA decay is inactive and decapping is partially defective be-
cause of the growth temperature (Fig. 6 C). An important result 
is that the Yjef-N deletion mutant complemented both the decay 
and growth defects caused by the absence of Edc3p (Fig. 6, 
B and C). Because the Yjef-N domain is necessary for P-body 
aggregation in exponentially growing cells, these results indi-
cate that Edc3p’s role in enhancing decay under these conditions 
is not dependent on its ability to form large P-body aggregates. 
In contrast, decay and growth were defective when either the 
∆Lsm or ∆FDF Edc3p variants were expressed (Fig. 6, B and C), 
which indicates that both the Lsm and FDF domains are neces-
sary for Edc3p to enhance decapping. Because these are the do-
mains that interact with Dcp2p and Dhh1p, this result suggests 
that Edc3p may enhance decapping by binding to and directly 
affecting the function of the decapping machinery.
Discussion
The formation of cytoplasmic P-bodies can be associated with 
translation repression and/or mRNA decapping and degrada-
tion. An unresolved issue is how P-bodies form and the func-
tional significance of assembly into larger scale aggregates. 
In the simplest model, the formation of P-bodies can be consid-
ered to occur in at least two distinct steps: an initial step wherein 
an individual mRNA is associated with various proteins to form 
an mRNP capable of aggregation into a larger P-body, and a 
second step whereby individual mRNPs are then aggregated to-
gether to form P-bodies of suffi  cient size to be visible in the 
light microscope. However, it also remains possible that there 
are intermediate steps in the aggregation of mRNPs that can as-
semble collections of mRNPs too small to be seen in the light 
microscope. By examination of P-body formation in yeast, we 
were able to identify important interactions that promote 
P-body formation. These interactions suggest an initial model for 
P-body assembly involving interactions of subcomplexes of 
core P-body components with the mRNA and each other, fol-
lowed by aggregation of individual mRNPs, or small complexes 
of mRNPs, into larger P-bodies by a self-interaction domain of 
Edc3p and the Q/N-rich C-terminal tail of Lsm4p.
Assembly of a core P-body mRNP
A fi  rst step in the formation of P-bodies is the assembly of indi-
vidual mRNPs that contain P-body components. Our results, 
combined with previous observations described in this and the 
following paragraph, suggest a working model for the assembly 
of the core P-body components into a complex associated with 
mRNAs (Fig. 7). First, an initial step in P-body interaction 
could be the recruitment of the Dcp1, Dcp2, Edc3, and Dhh1 
proteins to the mRNA, most likely as a protein complex. The 
existence of this complex is based on the direct protein interac-
tions we observed between Dcp2p, Dhh1p, and Edc3p (Fig. 3). 
It should be noted that the interactions between Dcp2p, Dhh1p, 
and Edc3p may not occur simultaneously, given that they involve 
Figure 6.  P-body aggregation does not substantially affect mRNA decay. 
(A) Decay analysis of MFA2pG mRNA in wild-type, edc3∆, lsm4∆C, or 
lsm4∆C edc3∆ strains. Time points after transcriptional repression are indi-
cated above each lane. The half-life values shown on the right are in 
minutes and represent the mean and SD based on three experiments. 
(B) Decay analysis of MFA2pG mRNA in edc3∆ or control strains carrying 
the temperature-sensitive allele dcp2-7 performed at 24°C, where dcp2-7 is 
partially active. The dcp2-7 edc3∆ strain contained plasmids expressing 
no Edc3p, Flag-tagged full-length Edc3p, or versions of Flag-tagged Edc3p 
in which the Lsm, FDF, or Yjef-N domains were deleted. The half-life values 
are in minutes and represent the mean and SD based on four experiments. 
(C) Growth of the dcp2-7 ski3∆ control strain or the dcp2-7 ski3∆ edc3∆ 
strain expressing no Edc3p, Flag-tagged full-length Edc3p, or versions of 
Flag-tagged Edc3p in which the Lsm, FDF, or Yjef-N domains were deleted 
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the same domains of Dcp2p and Dhh1p. Dcp1p is likely to be a 
component of this complex based on the direct physical interac-
tion between yeast Dcp1p and Dcp2p (Steiger et al., 2003; She 
et al., 2006), which is required for Dcp1p to be recruited into 
P-bodies (Teixeira and Parker, 2007). Moreover, a complex of 
Dcp1p–Dcp2p–Edc3p purifi  es together from yeast (Gavin et al., 
2006), and a similar complex copurifi  es from mammalian cells 
that includes the homologue of Dhh1p, Rck/p54, and an addi-
tional subunit, Ge-1 or Hedls (Fenger-Gron et al., 2005). Finally, 
Dcp1p, Dcp2p, Edc3p, and Dhh1p are recruited to P-bodies in-
dependently of other known P-body components (Teixeira and 
Parker, 2007). This suggests that one step in the formation of an 
mRNP that can accumulate in P-bodies is the recruitment of 
Dcp1p–Dcp2p–Edc3p–Dhh1p complexes to the mRNA.
Several observations suggest that a complex minimally 
consisting of Pat1p and the Lsm1-7p complex also associates 
with the mRNA during P-body assembly. First, Pat1p and the 
Lsm1-7p complex copurify from yeast (Bouveret et al., 2000; 
Tharun et al., 2000). Second, Pat1p is required for recruitment 
of the Lsm1-7p complex into P-bodies, and the deletion of 
Lsm1p affects the effi  ciency of Pat1p recruitment into P-bodies 
in part by shifting Pat1p into the nucleus (Teixeira and Parker, 
2007). Xrn1p is also likely to be part of the Pat1p–Lsm1-7p 
complex because it can copurify with these proteins (Bouveret 
et al., 2000). Finally, the Pat1p–Lsm1-7p complex appears to 
function somewhat independently of the Dcp1p–Dcp2p–Edc3p–
Dhh1p complex because Pat1p and Dhh1p can each indepen-
dently target mRNAs to P-bodies when overexpressed (Coller 
and Parker, 2005).
We suggest that an individual P-body mRNP forms, at 
least in part, as a result of recruitment of the Dcp1p–Dcp2p–
Edc3p–Dhh1p and Pat1p–Lsm1-7p–Xrn1p complexes to the 
mRNA, although their specifi  c location on the mRNA remains 
to be determined. In addition, the two subcomplexes may directly 
interact with each other while bound to the mRNA based on the 
identifi  cation of interactions between Pat1p with Dcp1p and 
Edc3p (Pilkington, G., and R. Parker, personal communication). 
An unresolved issue is whether there are other RNA binding 
proteins bound to the mRNA in this complex, if the body of the 
mRNA is largely naked of proteins, or if there are multiple cop-
ies of these components per mRNA, thereby coating the entire 
length of the transcript. One possibility is that Sbp1p, an abun-
dant RNA binding protein found in yeast P-bodies (Segal et al., 
2006), might bind to regions not covered by the Dcp1p–Dcp2p–
Edc3p–Dhh1p and Pat1p–Lsm1-7p–Xrn1p complexes. An im-
portant issue for future work will be to determine the stoichiometry 
and spatial arrangement of these complexes with regard to the 
mRNA, the precise timing of specifi  c interactions, and how the 
Figure 7.  Model for P-body assembly. First, two subcom-
plexes of conserved “core” proteins assemble onto mRNA 
through a series of direct interactions between their compo-
nents and with the mRNA. One of these subcomplexes is com-
posed of Dcp1p, Dcp2p, Dhh1p, and Edc3p, although Dcp2, 
Dhh1p, and Edc3p may or may not bind simultaneously with 
each other. The other subcomplex consists of Pat1p, Lsm1-7p, 
and Xrn1p. Individual core P-body mRNPs could then poten-
tially aggregate into larger assemblies through interactions 
dependent on the Edc3p YjeF-N domain and/or the Lsm4p 
Q/N-rich prionlike domain.JCB • VOLUME 179 • NUMBER 3 • 2007  446
mRNA is bound by this complex. Moreover, how an mRNA 
transitions from translation and how that relates to the formation 
of these complexes with the mRNA remains to be determined. 
As discussed in the next section, the association of either of the 
proposed core subcomplexes with an mRNP would provide a 
potential mechanism for the mRNP to be incorporated into larger 
scale P-body aggregates via either Edc3p or Lsm4p.
P-body aggregation is mediated by a self-
interaction domain of Edc3p and the Q/N-
rich C-terminal tail of Lsm4p
Several observations argue that Edc3p functions to aggregate 
either individual mRNPs or small mRNP complexes into larger 
microscopically visible P-bodies. First, strains lacking Edc3p 
show a loss of the small P-bodies seen in mid-log cultures of 
yeast (Figs. 1 A and 2). Second, the number and size of P-bodies 
seen in either dcp1∆ or xrn1∆ strains are reduced in dcp1∆ 
edc3∆ or xrn1∆ edc3∆ double mutants (Fig. 1 B). Third, edc3∆ 
cells show defects in P-body aggregation during glucose depri-
vation and other stresses (Figs. 1 A and 2 and not depicted). 
Fourth, there is a loss of P-bodies in lsm4∆C edc3∆ strains dur-
ing glucose deprivation (Fig. 5). Finally, we argue that Edc3p 
plays a role in the actual assembly of nontranslating mRNPs 
into larger visible structures because translation repression and 
mRNA decay are normal in edc3∆ strains (Figs. 2 and 6).
The Edc3 protein is a scaffolding protein that provides 
sites for protein interactions and interconnecting mRNPs. Our 
results indicate that both the YjeF-N and Lsm domain of Edc3p 
are required for it being able to contribute to P-body aggrega-
tion (Fig. 4). Because the YjeF-N domain interacts with itself 
(Fig. 3; Fromont-Racine et al., 2000; Marino-Ramirez and Hu, 
2002), its function in P-body aggregation is most probably to 
provide direct interaction between different Edc3p molecules. 
The role of the Lsm domain is presumably to bind to the Dcp1p–
Dcp2p–Dhh1p complex, which would be consistent with the 
role of Dcp2p in P-body assembly (Teixeira and Parker, 2007). 
Alternatively, although unlikely given its high degree of diver-
gence, the Lsm domain could oligomerize and/or bind RNA 
(He and Parker, 2000). The self-interaction of the Yjef-N domain 
and the interaction of the Lsm domain with mRNA or P-body 
components provide a cross-bridging mechanism for aggregating 
mRNPs together. Because Edc3p, its domain organization, and 
its localization to P-bodies are conserved in eukaryotic cells 
(Albrecht and Lengauer, 2004; Anantharaman and Aravind, 2004; 
Kshirsagar and Parker, 2004; Fenger-Gron et al., 2005), one might 
anticipate that Edc3p will play a role in P-body aggregation in 
other eukaryotes.
We identifi  ed the C-terminal prionlike domain of Lsm4p 
as another mechanism for the aggregation of mRNPs into micro-
scopically visible P-bodies. The key observation is that lsm4∆C 
edc3∆ strains show a dramatic reduction in P-bodies during glu-
cose deprivation compared with edc3∆ strains alone (Fig. 5). 
In addition, the C-terminal Q/N-rich domain of Lsm4p could 
be functionally replaced with the Q/N-rich prionlike domain of 
Rnq1p, a known yeast prion protein (Fig. 5). The simplest model is 
that when the Lsm1-7p complex is delivered to the mRNA in con-
junction with Pat1p (Teixeira and Parker, 2007), the Q/N-rich 
domain interacts either with itself or other Q/N-rich domains to 
aggregate mRNPs together in a manner similar to oligomerization 
of other prion domains, although in this case the aggregation 
would be readily reversible and not necessarily heritable.
Implications of a prionlike mechanism 
contributing to P-body aggregation
The contribution of a prionlike domain to yeast P-body assem-
bly is intriguing because of the other 107 proteins in yeast with 
prionlike domains (Michelitsch and Weissman, 2000); 47 of them 
are involved in mRNA transport, translation, or degradation or 
have other connections to RNA metabolism (Table S1 A, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200704147/DC1). 
For example, the yeast P-body components Ccr4p, Pop2p, Not1p, 
Not4p, Dhh1p, Edc3p, and all fi  ve Puf proteins, which regulate 
mRNA deadenylation and decapping (Wickens et al., 2002), 
all contain Q/N-rich regions. This abundance of Q/N domains 
in proteins involved in mRNA metabolism suggests that inter-
actions between these prionlike domains might also contribute 
in some cases to P-body assembly or other subcellular assem-
blies of mRNPs.
The role of a prionlike domain in P-body assembly in 
yeast has three implications for metazoan cells. First, although 
the prionlike domain of yeast Lsm4p is not conserved, several 
proteins found in metazoan P-bodies contain conserved Q/N-
rich domains, including Dcp2p, Ge-1/Hedls, and GW182 (Table 
S1 B), although these domains do not always meet the formal 
criteria for “prion domains” established earlier (Michelitsch 
and Weissman, 2000). This suggests that aggregation based on 
Q/N-rich regions will contribute to assembly of P-bodies in 
metazoans. Second, because Q/N-rich prionlike domains contri-
bute to stress granule formation in mammalian cells (Gilks et al., 
2004) and stress granules can merge or dock with P-bodies in 
human cells (Kedersha et al., 2005; Wilczynska et al., 2005), 
a reasonable hypothesis is that the juxtaposition of stress gran-
ules and P-bodies is mediated by a shared assembly mechanism 
based on prionlike domains. Finally, because Q/N-rich domains 
in Pum2 and cytoplasmic polyadenylation element binding pro-
tein have been suggested to play roles in the regulation of trans-
lation in neurons (Si et al., 2003; Vessey et al., 2006) and at least 
some neuronal RNA granules are similar to P-bodies (Barbee 
et al., 2006), one might anticipate that aggregation mechanisms 
into P-bodies based on Q/N domains will be important in the 
regulation of translation in neurons.
Efﬁ  cient P-body aggregation is not 
required for basic control of mRNA 
decay and translation repression
Our results argue that formation of microscopically visible 
P-bodies is not required for the basal control of translation and 
mRNA degradation. The key observation is that lsm4∆C edc3∆ 
strains are severely defective in P-body aggregation (Fig. 5) but 
competent for translation repression during glucose deprivation 
and show normal mRNA turnover rates (Figs. 5 and 6). The 
simplest interpretation is that the association of P-body compo-
nents with an individual mRNA is suffi  cient for a basal level of 
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out the possibility that, in the absence of Edc3p and the prion-
like domain of Lsm4p, aggregates too small to detect by the light 
microscope but nonetheless functional can still form. Consistent 
with the interpretation that large-scale aggregates do not strongly 
infl  uence translation repression or mRNA turnover, microscopi-
cally visible P-bodies can be depleted in metazoan cells by knock-
down of Lsm1p or Lsm3p without affecting miRNA-mediated 
repression (Chu and Rana, 2006; Eulalio et al., 2007b), knock-
down of GW182 without affecting mRNA decay stimulated by 
AU-rich elements (Stoecklin et al., 2006), or knockdown of any 
one of several P-body components without affecting nonsense 
mediated decay (Eulalio et al., 2007b).
An unresolved issue is the function of aggregation of indi-
vidual mRNPs into larger P-body structures. The conservation 
of P-bodies strongly argues that the aggregation of nontranslat-
ing mRNPs together into larger structures does confer some 
adaptive function. For example, sequestration might increase 
the effectiveness of translation repression by limiting the access 
of the translation machinery to mRNA and reducing the likeli-
hood of disassembly of repression complexes on mRNAs. Thus, 
aggregation could have a subtle effect on the persistence, or de-
gree of, translation repression and/or decay rates either in gen-
eral or on a specifi  c subset of mRNA. Alternatively, aggregation 
could be important for effi  cient transport of mRNA to specifi  c 
subcellular regions. Finally, aggregation may be more critical 
for limiting interactions of nontranslating mRNA with other 
cellular components. For example, aggregation of such mRNA 
into P-bodies would presumably limit base pairing between un-
translating mRNA and mRNA in polysomes that might be det-
rimental for translation. Similarly, aggregation into P-bodies 
may protect untranslating mRNA from degradation by the exo-
some or infl  uence the specifi  city of protein interactions with 
target mRNA by concentrating RNA binding proteins with their 
targets and limiting their access to off-target mRNA. An impor-
tant goal of future work will be a thorough analysis of strains 
specifi  cally defi  cient in P-body aggregation to determine how 
mRNA metabolism is now altered.
Materials and methods
Yeast strains, growth conditions, plasmids, and oligonucleotides
Strains used in this study are listed in Table S2 (available at http://www
.jcb.org/cgi/content/full/jcb.200704147/DC1). Strains with C-terminal 
GFP fusion proteins were derived from strains described previously (Sheth 
and Parker, 2003; Teixeira and Parker, 2007). C-terminal deletion of 
LSM4 was constructed using a PCR-based protocol (Longtine et al., 1998). 
The lsm4∆ edc3∆ Dcp2GFP strain was constructed from a single cross be-
tween yRP2164 and a haploid lsm4∆ strain derived from a heterozygous 
diploid lsm4∆ strain (Open Biosystems). Strains were grown at 30°C unless 
otherwise stated in either yeast extract/peptone medium (YP) or synthetic 
medium (SC) supplemented with appropriate amino acids and 2% glu-
cose. Respiratory-deﬁ  cient (petite) derivatives of wild-type or edc3∆ strains 
were obtained by screening for colonies that had spontaneously lost the 
ability to grow on glycerol. Plasmids and oligonucleotides used in this 
study are listed in Table S3.
Microscopy
Cultures were grown to OD 600 of 0.3–0.4, collected by centrifugation, 
washed, and resuspended in SC plus amino acids supplemented with glu-
cose. For glucose depletion in Fig. 1, after washing and resuspension in YP 
without glucose, cells were incubated in a ﬂ  ask in a shaking water bath for 
10 min and washed with SC without glucose. For glucose depletion with-
out aeration, cells were washed and resuspended in SC without glucose 
and incubated in a microcentrifuge tube. For glucose depletion with aera-
tion, after washing and resuspension in SC without glucose, cells were in-
cubated in a ﬂ  ask in a shaking water bath for 10 min. Images for Fig. 1 
were acquired with a confocal microscope (PCM 2000; Nikon) using an 
objective (Plan Apo 100× 1.4 NA; Nikon) with 3× magniﬁ  cation using a 
photomultiplier tube (R928; Hamamatsu Photonics) and software (Compix 
Media). All images are a maximum intensity projection of a z series com-
pilation of 6–10 images performed by Compix software. Images for Figs. 
2, 4, and 5 were acquired with a deconvolution microscope (Deltavision 
RT; Applied Precision) using an objective (UPlan Sapo 100× 1.4 NA; 
Olympus). They were collected using software (softWoRx) as 512 × 512-
pixel ﬁ  les with a camera (CoolSNAP HQ; Photometrics) using 1 × 1 bin-
ning. Images are maximum intensity projections of a z series compilation 
of 15 images made using Image J and have been adjusted to the same 
contrast range except in Fig. 5 B.
Polysome analysis
Cultures at OD 600 of 0.4–0.6 were split, washed, and resuspended with 
YP with or without glucose, and then incubated in a shaking water bath at 
30°C for 10 min. Cells were harvested by centrifugation at 4,000 rpm for 
1 min at 4°C over ice, washed in lysis buffer (10 mM Tris-HCl, pH 7.4, 100 mM 
NaCl, and 30 mM MgCl2), and stored at −80°C. Lysates were prepa-
red by vortexing cells with glass beads at 4°C in lysis buffer containing 
0.5 mg/ml heparin and 1mM DTT and clariﬁ  ed by centrifugation for 2 min 
at 4,000 rpm at 4°C. 10 A254 units of clariﬁ  ed lysate were loaded on 
15–50% sucrose gradients containing 50 mM Tris-HCl, pH 7.0, 50 mM 
NH4CL, 12 mM MgCl2, and 1 mM DTT, sedimented in a rotor (SW41; 
Beckman Coulter) using an ultracentrifuge (L8-M; Beckman Coulter) at 4°C 
for 2.5 h at 39,000 rpm, and collected while the A254 value was moni-
tored using a continuous ﬂ  ow cell UV detector (UA-6; Teledyne Isco).
Yeast two-hybrid assay
Two-hybrid fusion plasmids were constructed by homologous recombina-
tion of PCR products into pOAD or pOBD-2 in yeast strains PJ694a and 
PJ694α (James et al., 1996) as described previously (Cagney et al., 
2000). Two-hybrid plasmids and strains were obtained from the Yeast Re-
source Center (provided by S. Fields, University of Washington, Seattle, 
WA). Interactions were measured by β-galactosidase plate assays in dip-
loids containing pOAD and pOBD-2 derivatives.
Protein puriﬁ  cation, in vitro protein–protein interaction assays, 
and Western analysis
Puriﬁ   cation of His-Dcp2(1–300)-Flag and His-Dcp2(102–300)-Flag was 
performed as described previously (She et al., 2006). GST-tagged versions 
of Dhh1p were expressed in E. coli BL-21 and puriﬁ  ed as described previ-
ously (Cheng et al., 2005), except that only the ﬁ  rst puriﬁ  cation step on 
glutathione-Sepharose was performed. The GST-Dhh (46–461) plasmid 
was provided by H. Song (Institute of Molecular and Cell Biology, Proteos, 
Singapore). The His-tagged FDF domain of Edc3p was puriﬁ  ed from E. coli 
BL-21 (DE3) using His-bind resin (Novagen) after incubation with 1 mg/ml 
lysozyme for 30 min on ice in 20 mM Tris-HCl, pH 7.9, 500 mM NaCl, 
and 5 mM imidazole containing complete protease inhibitors without EDTA 
(Pierce Chemical Co.) followed by sonication. Lysates containing a His-tagged 
Lsm domain of Edc3p were prepared from E. coli BL-21 (DE3) by lysing cells 
in 20 mM Tris-HCl, pH 7.9, 100 mM NaCl, and 10% glycerol containing 
1 mg/ml lysozyme for 30 min followed by sonication and clariﬁ  cation.
Binding reactions were performed at 4°C in binding buffer (50 mM 
Hepes, pH 7.0, 100 mM NaCl, 1 mM DTT, 2 mM MnCl2, 2 mM MgCl2, 
1% Triton X-100 (Fisher Scientiﬁ  c), 10% glycerol, and 10 mg/ml BSA) con-
taining  20 ng/μl His-Lsm or His-FDF and 25–67.5 ng/μl GST-Dhh1 or 
His-Dcp2-Flag proteins. Because of the low concentration of His-Lsm in the 
extracts, the NaCl concentration was increased to 225 mM. Glutathione-
Sepharose 4B (GE Healthcare) and anti-Flag M2 agarose (Sigma-Aldrich) 
was used to pull down GST-Dhh1 and His-Dcp2-Flag, respectively. Western 
analysis was performed using polyclonal anti-His antibody (Santa Cruz 
Biotechnology, Inc.).
Western analysis of Edc3 and Dcp2GFP proteins was performed by 
preparing extracts from wild-type and edc∆ strains expressing Flag-tagged 
versions of Edc3p. Flag-tagged full-length ∆Lsm and ∆FDF Edc3 proteins 
were detected using anti-Flag M2 monoclonal antibody (Sigma-Aldrich). 
The ∆Yjef-N Edc3 protein was detected using a polyclonal antibody raised 
in rabbits to a puriﬁ  ed His-tagged FDF domain (Cocalico Biologicals) be-
cause it co-migrated with a nonspeciﬁ  c band detected by the anti-Flag anti-
body. Dcp2GFP was detected using anti-GFP antibody (Covance).JCB • VOLUME 179 • NUMBER 3 • 2007  448
mRNA half-life analysis
Cells were grown to OD 600 of 0.3–0.4 in media containing 2% galac-
tose at 30 or 24°C for experiments using dcp2-7, and then transcription 
was repressed by resuspending in media with 4% glucose. Total RNA was 
extracted (Caponigro et al., 1993), and the amount of MFA2pG mRNA 
was quantiﬁ  ed by Northern analysis with oRP140 (Caponigro and Parker, 
1995) using a phosphorimager (Molecular Dynamics). Loading corrections 
were performed as described previously (Caponigro et al., 1993).
Online supplemental material
Table S1 lists Q/N-rich regions in proteins involved in RNA metabolism 
and location of conserved Q/N-rich regions in metazoan P-body proteins. 
Table S2 lists yeast strains used in this paper. Table S3 lists plasmids and 
oligonucleotides used in this paper. Fig. S1 shows the effect of Edc3p do-
main deletions on Dhh1GFP foci. Fig. S2 shows levels of mutant Edc3p 
proteins and Dcp2GFP. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200704147/DC1.
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